Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: question re comt inhibitors
Hi janet: Intriguing difference in the mechanism of
action, no? I thought I understood the blood-brain
barrier business, but now I, too, am confused. Would
somebody in the audience please clarify?
Carole H.
--- janet paterson <janet313@xxxxxxxxxxx> wrote:
> hi all
>
> after reviewing the pmid abstracts on comt
> inhibitors
> i started mulling
>
> i hadn't realized
> that tolcapone crosses the blood brain barrier
> while entacapone doesn't
>
> if the work that this class of med does
> [saving lovely levodopa from arterial ambush by
> those vile venous comt conspirators]
> is done in the bloodstream prior to arrival at the
> brain station
> why would either of them have to cross the blood
> brain barrier?
> anyway?
>
> just a late nite thote about cone pone
>
> janet
>
> janet paterson
> 52 now / 41 dx / 37 onset
> 613 256 8340 po box 171 almonte ontario canada K0A
> 1A0
> a new voice:
> <>
> <janet313@xxxxxxxxxxx>
>
=====
__________________________________________________
Do You Yahoo!?
Bid and sell for free at
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance